Business description: TearLab Corporation

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Sales by Activity: TearLab Corporation

Fiscal Period: December 2019 (USD)

Diagnostic Kits / Equipment

22.66M

Geographical breakdown of sales: TearLab Corporation

Fiscal Period: December 2019 (USD)

United States

21.29M

Rest of the World

1.37M

Executive Committee: TearLab Corporation

Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Chief Tech/Sci/R&D Officer - 2006-09-30
Chief Tech/Sci/R&D Officer 73 -

Composition of the Board of Directors: TearLab Corporation

Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Director/Board Member 62 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Company details: TearLab Corporation

TearLab Corp., Inc.

940 South Kimball Avenue

76092, Southlake

+855-832-7522

http://www.tearlab.com
address TearLab Corporation

Glasses, Spectacles & Contact Lenses

Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-2.76%-26.60%+1.32% 170B
-1.00%0.00%-11.52%+14.41% 111B
-2.46%-0.20%-24.05%+4.65% 107B
-0.72%-0.07%-47.36%-10.90% 75.95B
+0.46%+2.85%+3.63%+72.08% 60.37B
-0.65%+6.59%+11.44%+66.40% 53.53B
-0.20%-0.92%-6.09%-31.29% 49.11B
-2.21%-3.38%-17.90%+15.57% 40.6B
-4.04%-3.75%+25.66%+0.20% 31.47B
Average -1.16%+0.25%-10.31%+14.72% 77.67B
Weighted average by Cap. -0.98%-0.04%-16.24%+12.17%
  1. Stock Market
  2. Stocks
  3. Stock
  4. Company TearLab Corporation